- Patent Title: Quinolines that modulate SERCA and their use for treating disease
-
Application No.: US18229474Application Date: 2023-08-02
-
Publication No.: US11992487B2Publication Date: 2024-05-28
- Inventor: Russell Dahl
- Applicant: Neurodon Corporation
- Applicant Address: US IN Crown Point
- Assignee: Neurodon Corporation
- Current Assignee: Neurodon Corporation
- Current Assignee Address: US IN Crown Point
- Agency: McCarter & English, LLP
- Agent Steven G. Davis
- Main IPC: A61K31/4706
- IPC: A61K31/4706 ; A61K31/4709 ; A61P3/10
Abstract:
Provided herein are compounds of Formula I, pharmaceutical compositions thereof, and methods of their use for treating, preventing, or ameliorating one or more symptoms of a neurological disease, neurodegenerative disorder, or diabetes.
Public/Granted literature
- US20240016793A1 QUINOLINES THAT MODULATE SERCA AND THEIR USE FOR TREATING DISEASE Public/Granted day:2024-01-18
Information query
IPC分类:
